Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer.
Cancer treatment reviews·2012
Topological Frustration of Ångström-Confined Water for Stable Aqueous Zinc-Ion Batteries.
Advanced materials (Deerfield Beach, Fla.)·2026
Recurrent nontraumatic acute subdural hematoma secondary to ruptured accessory meningeal artery aneurysm: A case report and literature review.
Journal of cerebrovascular and endovascular neurosurgery·2026